World

UAE Ambassador presents credentials to President of Kenya

Sep 03, 2023

Nairobi [Kenya], September 3: Dr Salem Ibrahim Al Naqbi presented his credentials as Ambassador Extraordinary and Plenipotentiary of the UAE to Kenya to President William Samoei Ruto of Kenya during a ceremony at the Presidential Palace in Nairobi.
During the reception, Al Naqbi conveyed to President Ruto the greetings of UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan, His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President, Prime Minister and Ruler of Dubai, and His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Minister of the Presidential Court, well as their wishes for further development and prosperity for the government and people of Kenya.
For his part, President Ruto expressed his greetings to UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan, His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President, Prime Minister and Ruler of Dubai, and His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Minister of the Presidential Court, and his wishes for further growth and prosperity for the government and people of the UAE.
President Ruto wished the UAE Ambassador success in his work to enhance ties between the two countries, stressing his country's readiness to provide all possible support to facilitate his duties.
The Ambassador expressed his pride in representing the UAE in Kenya and his keenness to continue developing relations in various fields between the two friendly nations.
Source: Emirates News Agency

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025